AI-ECG for Time-Resolved Prediction of HFrEF
Electrocardiogram-Based Deep Learning for Time-Resolved Prediction of Heart Failure With Reduced Ejection Fraction: A Multinational Study
1 other identifier
observational
286,709
1 country
1
Brief Summary
This study aims to develop and validate a deep learning-based electrocardiogram (ECG) model for predicting the future risk of heart failure with reduced ejection fraction (HFrEF). The model is trained using raw 12-lead ECG data and generates individualized, time-resolved risk estimates over a 5-year period. Data are obtained from multiple cohorts, including Zhongshan Hospital, Shanghai Tenth People's Hospital, and Beth Israel Deaconess Medical Center, representing diverse populations across China and the United States. The model is designed to identify individuals at elevated risk of developing HFrEF before the onset of overt clinical disease. The performance of the model is evaluated using multiple complementary metrics, including discrimination, calibration, and clinical utility. In addition, interpretability analyses are conducted to explore the physiological relevance of ECG features associated with predicted risk. This study seeks to provide an accessible and scalable tool for early risk stratification of heart failure, with the potential to support timely clinical decision-making and improve patient outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedFirst Submitted
Initial submission to the registry
April 2, 2026
CompletedFirst Posted
Study publicly available on registry
April 9, 2026
CompletedApril 9, 2026
April 1, 2026
9.8 years
April 2, 2026
April 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incident Heart Failure With Reduced Ejection Fraction (HFrEF)
Occurrence of heart failure with reduced ejection fraction (HFrEF), defined as a left ventricular ejection fraction (LVEF) ≤40% during follow-up, as determined by transthoracic echocardiography. Both prevalent and incident cases identified from ECG-echocardiography data are included.
Up to 5 years
Study Arms (1)
Overall Study Population
Participants from three independent cohorts (Zhongshan Hospital, Shanghai Tenth People's Hospital, and Beth Israel Deaconess Medical Center) who underwent standard 12-lead electrocardiography and echocardiographic evaluation. These data were used to develop and externally validate a deep learning model for time-to-event prediction of incident heart failure with reduced ejection fraction (HFrEF). No interventions were assigned, as this was an observational study based on routinely collected clinical data.
Eligibility Criteria
Participants were derived from three independent cohorts, including Zhongshan Hospital, Shanghai Tenth People's Hospital, and Beth Israel Deaconess Medical Center. The study population included adult patients who underwent routine ECG and echocardiographic evaluation in real-world clinical settings.
You may qualify if:
- Adults aged ≥18 years Underwent standard 12-lead electrocardiography (ECG) Underwent transthoracic echocardiography with available LVEF measurement Availability of paired ECG-echocardiography data Data available for follow-up assessment
You may not qualify if:
- Missing or incomplete ECG or echocardiography data Poor-quality ECG recordings unsuitable for analysis Missing key clinical variables required for model development
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shanghai Zhongshan Hospitallead
- Shanghai 10th People's Hospitalcollaborator
- Beth Israel Deaconess Medical Centercollaborator
Study Sites (1)
Unknown Facility
Shanghai, Shanghai Municipality, 200436, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 2, 2026
First Posted
April 9, 2026
Study Start
February 1, 2014
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
April 9, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
This study uses retrospective clinical data that are not publicly shareable.